Ej. Boviatsis et al., GENE-TRANSFER INTO EXPERIMENTAL BRAIN-TUMORS MEDIATED BY ADENOVIRUS, HERPES-SIMPLEX VIRUS, AND RETROVIRUS VECTORS, Human gene therapy, 5(2), 1994, pp. 183-191
Three vectors derived from retrovirus, herpes simplex virus type 1 (HS
V), and adenovirus were compared in cultured rat 9L gliosarcoma cells
for gene transfer efficiency and in a 9L, rat brain tumor model for hi
stologic pattern and distribution of foreign gene delivery, as well as
for associated tumor necrosis and inflammation. At a multiplicity of
infection of 1, in vitro transfer of a foreign gene (lacZ from Escheri
chia coil) into cells was more efficient with either the replication-d
efective retrovirus vector or the replication-conditional thymidine ki
nase (TK)-deficient HSV vector than with the replication-defective ade
novirus vector. In vivo, stereotactic injections of each vector into r
at brain tumors revealed three main histopathologic findings: (i) retr
ovirus and HSV vector-mediated gene transfer was relatively selective
for cells within the tumor, whereas adenovirus vector-mediated gene tr
ansfer occurred into several types of endogenous neural cells, as well
as into cells within the tumor; (ii) gene transfer to multiple infilt
rating tumor deposits without apparent gene transfer to intervening no
rmal brain tissue occurred uniquely in one animal inoculated with the
HSV vector, and (iii) extensive necrosis and selective inflammation in
the tumor were evident with the HSV vector, whereas there was minimal
evidence of tumor necrosis and inflammation with either the retroviru
s or adenovirus vectors.